Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure

American Journal of the Medical Sciences

Volumn 331, Issue 1, 2006, Pages 30-34

  Khouzam, Rami N ^a   Dishmon, Dwight A ^a   Farah, Victor ^a   Flax, Sherri D ^a   Carbone, Laura D ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

African Americans; Aldosteronism; Heart failure; Hyperthyroidism

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CALCIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; SPIRONOLACTONE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BONE DEFECT; CALCIUM BLOOD LEVEL; CALCULATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HEALTH CENTER; HEART LEFT VENTRICLE OVERLOAD; HOSPITALIZATION; HUMAN; HYPERALDOSTERONISM; MALE; MEASUREMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

EID: 31744441980     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200601000-00009     Document Type: Article

References (40)

1. Swedberg K, Eneroth P, Kjekshus J, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990;82:1730-36.
2. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-29.
3. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-97.
4. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34.
5. Anker SD, Clark AL, Teixeira MM, et al. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 1999;83:612-15.
6. Lee AH, Mull RL, Keenan GF, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994; 96:35-41.
7. Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207.
8. Conn JW. Presidential address. Part I: Painting background. Part II: Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955;45:3-17.
9. Mader IJ, Iseri LT. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid. Am J Med 1955;19:976-88.
10. Milne MD, Muehrcke RC, Aird I. Primary aldosteronism. Quart J Med 1957;26:317-35.
11. Horton R, Biglieri EG. Effect of aldosterone on the metabolism of magnesium. J Clin Endocrinol Metab 1962;22:1187-92.
12. Rastegar A, Agus Z, Connor TB, et al. Renal handling of calcium and phosphate during mineralocorticoid "escape" in man. Kidney Int 1972;2:279-86.
13. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 1985;78:385-90.
14. Rossi E, Sani C, Perazzoli F, et al. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 1995;8:884-93.
15. Chhokar VS, Sun Y, Bhattacharya SK, et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871-78.
16. Chhokar VS, Sun Y, Bhattacharya SK, et al. Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol 2004;287:H2023-6.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
18. Stefenelli T, Pacher R, Woloszczuk W, et al. Parathyroid hormone and calcium behavior in advanced congestive heart failure [German]. Z Kardiol 1992;81:121-5.
19. Schmid C, Kiowski W. Hyperparathyroidism in congestive heart failure. Am J Med 1998;104:508-09.
20. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-12.
21. Stein MS, Scherer SC, Walton SL, et al. Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol 1996;44:375-83.
22. Christ E, Linka A, Junga G, et al. Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease [German]. Schweiz Med Wochenschr 1996;126:1553-9.
23. Stanbury SW. Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981. J R Coll Physicians Lond 1981;15:205-09,12-7.
24. McMurtry CT, Young SE, Downs RW, et al. Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc 1992;40:343-7.
25. Fahrleitner A, Dobnig H, Obernosterer A, et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med 2002;17:663-9.
26. Chel VG, Ooids ME, Popp-Snijders C, et al. Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Min Res 1998;13:1238-42.
27. Gehr MK, Goldberg M. Hypercalciuria of mineralocorticoid escape: clearance and micropuncture studies in the rat. Am J Physiol. 251(5 Pt 2):F879-F88.
28. Fertig A, Webley M, Lynn JA. Primary hyperparathyroidism in a patient with Conn's syndrome. Postgrad Med J 1980;56:45-7.
29. Hellman DE, Kartchner M, Komar N, et al. Hyperaldosteronism, hyperparathyroidism, medullary sponge kidneys, and hypertension. JAMA 1980;244:1351-3.
30. Vidal A, Sun Y, Bhattacharya SK, et al. The calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006 (in press).
31. 2 in peripheral blood mononuclear cells. Circulation 2005;111:51-7.
32. Gerling IC, Sun Y, Ahokas RA, et al. Aldosteronism: an immunostimulatory state precedes the proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol 2003;285:H813-21.
33. Ahokas RA, Warrington KJ, Gerling IC, et al. Aldosteronism and peripheral blood mononuclear cell activation. A neuroendocrine-immune interface. Circ Res 2003;93:e124-35.
34. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart. Role of oxidative stress. Am J Pathol 2002;161:1773-81.
35. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994;105:897-904.
36. Grey A, Mitnick MA, Masiukiewicz U, et al. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 1999;140:4683-90.
37. Takahashi S, Hakuta M, Aiba K, et al. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels. Endocr Relat Cancer 2003;10:403-7.
38. Kusec V, Smalcelj R, Puretic Z, et al. Interleukin-6, transforming growth factor-beta 1, and bone markers after kidney transplantation. Calcif Tissue Int 2004;75:1-6.
39. Weinstein RS, Bell NH. Diminished rates of bone formation in normal black adults. N Engl J Med 1988;319:1698-701.
40. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, et al. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 2002;57:51-5.